Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Strategic Perspectives 2001: Premenstrual Dysphoric Disorder - A Target Area For a Portfolio Gap

Published by: Datamonitor

Published: Aug. 22, 2001 - 64 Pages


Table of Contents


DATAMONITOR HEALTHCARE

CONTACT DETAILS

EXECUTIVE SUMMARY

Scope

Datamonitor insight into the PMDD market

Key metrics

TABLE OF CONTENTS

EPIDEMIOLOGY

Definition

Diagnostic criteria

Causes

Comorbidities

Mood disorders

Eating disorders

Patient potential

Prevalence

Epidemiological conclusion

CLINICAL PRACTICE

Introduction

Diagnosis

Guidelines in existence

Diagnosis rate

Treatment

Breakdown of PMDD in anxiety disorders

First line PMDD treatment

Overall PMDD treatment

Influence on PMDD marketing

The strength of efficacy data

Opportunity for noradrenergics

Lack of awareness amongst patients

CURRENT PMDD MARKET

The use of antidepressants in PMDD

Sarafem

Zoloft

Effexor

Luvox

Serzone

Conclusion

The global PMDD market 2001

THE FUTURE DECODED

Unmet needs in treating PMDD

The PMDD R&D pipeline

Paroxetine CR

PH80

The PMDD market 2001-2008

Factors influencing the future PMDD market

Future drug launches

PMDD market forecast to 2008

PMDD market forecast 2005

PMDD market forecast 2008

APPENDIX

Datamonitor's Central Nervous System Business Unit

Table of tables

Table of figures

Epidemiology

Clinical trials

Websites

R&D research methodology

Introduction

Hypothesis formulation

Hypothesis testing

Data verification and quality control

Physician research questionnaire

Diagnosis

Treatment

Unmet needs

Pricing data

Introduction

Source prices

Ex-manufacturer, wholesaler and retail prices

Data validation and margin calculation

Quality control

Patent data





































Abstract

Datamonitor's Strategic Perspectives 2001: Anxiety Disorders series of eight reports form a comprehensive review of major anxiety and eating disorder markets. Each report utilizes primary research data in the seven leading healthcare markets and investigates the current state of affairs in each market. Furthermore they provide an in-depth analysis of the current pipeline, estimated drug launches and the future direction of each anxiety disorder.

Anxiety Disorders covered:

  • Eating Disorders (Anorexia Nervosa and Bulimia Nervosa)
  • Generalized Anxiety Disorder
  • Obsessive Compulsive Disorder
  • Panic Disorder
  • Phobias (Specific Phobia and Agoraphobia)
  • Post Traumatic Stress Disorder
  • Premenstrual Dysphoric Disorder
  • Social Anxiety Disorder

    Get Full Details About This Report >>
  • US: 800.298.5699
    Int'l: +1.240.747.3093
    Buy this Report

    Price and Delivery Options

    See related reports or call the number above for help from a research specialist.


     

    About MarketResearch.com
    MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

     

    © MarketResearch.com 2008